Haemonetics (HAE) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.92 +0.07%
EPS Growth %: 0.0%
Financial Fact:
Net income: 0.39
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Net income: 0.39
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $318.2 million versus the consensus estimate of $313.12 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
